Provectus Biopharmaceuticals (PVCT) null Earnings

9MayConfirmed
Nov 18
Q3 2018
Feb 19
May 19
-0.01
-0.01
-0.01
-0.01

Details

Expected EPS
N/A
Actual EPS
-0.0057
Surprise EPS
-0.01
Surprise Percent
+∞%

Description

Provectus Biopharmaceuticals (PVCT) has reported earnings of -0.0057 per share for .

0 Comments

Share your thoughts